المؤلفون: John Td Wood

مصطلحات موضوعية: Business, Consumer protection, Marketing

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::af7bd4432a46cc2f79f98babaf6225a5
https://doi.org/10.22459/rt.02.2017.36

المؤلفون: John, TD, Sender, LS, Bota, DA

المصدر: Journal of adolescent and young adult oncology, vol 5, iss 3
John, TD; Sender, LS; & Bota, DA. (2016). Cognitive Impairment in Survivors of Adolescent and Early Young Adult Onset Non-CNS Cancers: Does Chemotherapy Play a Role?. JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 5(3), 226-231. doi: 10.1089/jayao.2015.0025. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4jp8888z

مصطلحات موضوعية: Adult, Male, Adolescent, Oncology and Carcinogenesis, Nursing, chemotherapy, humanities, health-related quality of life, Young Adult, Risk Factors, cognitive dysfunction, Neoplasms, Public Health and Health Services, Humans, late effects, Female, Survivors, survivorship

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1da7f6c978ad391b489d28e0592cf296
https://escholarship.org/uc/item/4jp8888z

المؤلفون: Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: akshay.sharma@stjude.org., John TD; Department of Pediatrics, Hematology, Oncology, Stem Cell, and Regenerative Medicine, Stanford University, Palo Alto, CA, USA.

المصدر: The Lancet. Haematology [Lancet Haematol] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

المؤلفون: John TD; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA., Maron G; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Abraham A; Center for Cancer and Immunology Research, CETI, Children's National Hospital, Washington, District of Columbia, USA., Bertaina A; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA., Bhoopalan SV; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Bidgoli A; Division of Blood and Marrow Transplantation, Children's Healthcare of Atlanta, Aflac Blood and Cancer Disorders Center, Emory University, Atlanta, Georgia, USA., Bonfim C; Pediatric Blood and Marrow Transplantation Division and Pelé Pequeno Príncipe Research Institute, Hospital Pequeno Príncipe, Curitiba, Brazil., Coleman Z; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., DeZern A; Bone Marrow Failure and MDS Program, John Hopkins Medicine, Baltimore, Maryland, USA., Li J; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, Australia., Louis C; Zentalis Pharmaceuticals, New York, New York, USA., Oved J; Stem Cell Transplantation and Cellular Therapies Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Pavel-Dinu M; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA., Purtill D; Department of Haematology, Fiona Stanley Hospital, Perth, Western Australia, Australia., Ruggeri A; IRCCS Ospedale San Raffaele, Segrate, Milan, Italy., Russell A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wynn R; Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Boelens JJ; Stem Cell Transplantation and Cellular Therapies Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Prockop S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Electronic address: akshay.sharma@stjude.org.

المصدر: Cytotherapy [Cytotherapy] 2024 Jul; Vol. 26 (7), pp. 660-671. Date of Electronic Publication: 2024 Feb 20.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 100895309 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-2566 (Electronic) Linking ISSN: 14653249 NLM ISO Abbreviation: Cytotherapy Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/methods , Hematopoietic Stem Cell Transplantation*/adverse effects , Genetic Therapy*/methods, Humans ; Hematopoietic Stem Cells/cytology ; Cell- and Tissue-Based Therapy/methods ; Infections/therapy ; Infections/etiology

المؤلفون: Sánchez LM; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., George A; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Friend BD; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Bhar S; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Sasa G; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Doherty EE; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Craddock J; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Steffin D; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Salem B; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Yassine K; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Omer B; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Martinez C; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Leung K; Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Krance RA; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., John TD; Department of Pediatrics, Division of Hematology/Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

المصدر: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2024 May; Vol. 41 (4), pp. 260-272. Date of Electronic Publication: 2023 Dec 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8700164 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0669 (Electronic) Linking ISSN: 08880018 NLM ISO Abbreviation: Pediatr Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: beta-Thalassemia*/therapy , beta-Thalassemia*/complications , Hematopoietic Stem Cell Transplantation*/methods , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control, Humans ; Infant ; Child, Preschool ; Child ; Adolescent ; Alemtuzumab/therapeutic use ; Transplantation, Homologous ; Transplantation Conditioning/methods ; Retrospective Studies

المؤلفون: Lozano Chinga MM; Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA.; University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA., Bertuch AA; Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA., Afify Z; Primary Children's Hospital, University of Utah, Salt Lake City, Utah, USA., Dollerschell K; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA., Hsu JI; Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA., John TD; Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA., Rao ES; Johns Hopkins Hospital, Baltimore, Maryland, USA., Rowe RG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA., Sankaran VG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA., Shimamura A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA., Williams DA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, Massachusetts, USA., Nakano TA; Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado, USA.

المصدر: American journal of medical genetics. Part A [Am J Med Genet A] 2023 Jul; Vol. 191 (7), pp. 1826-1835. Date of Electronic Publication: 2023 Apr 17.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4833 (Electronic) Linking ISSN: 15524825 NLM ISO Abbreviation: Am J Med Genet A Subsets: MEDLINE

مواضيع طبية MeSH: Bone Marrow Diseases*/diagnosis , Bone Marrow Diseases*/genetics , Pancytopenia* , Hematologic Diseases*, Humans ; Syndrome ; Bone Marrow Failure Disorders ; Transcription Factors/genetics ; Phenotype ; MDS1 and EVI1 Complex Locus Protein/genetics

المؤلفون: John TD; Center for Cell and Gene Therapy, Baylor College of Medicine.; Texas Children's Cancer and Hematology Center, Texas Children's Hospital.; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Namazzi R; Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda., Chirande L; School of Medicine, The Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Tubman VN; Center for Cell and Gene Therapy, Baylor College of Medicine.; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

المصدر: Current opinion in hematology [Curr Opin Hematol] 2022 Nov 01; Vol. 29 (6), pp. 275-280. Date of Electronic Publication: 2022 Sep 21.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lippincott Williams And Wilkins Country of Publication: United States NLM ID: 9430802 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-7048 (Electronic) Linking ISSN: 10656251 NLM ISO Abbreviation: Curr Opin Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/therapy , Graft vs Host Disease* , Hematopoietic Stem Cell Transplantation*/adverse effects, Africa South of the Sahara/epidemiology ; Child ; Humans ; Quality of Life

المؤلفون: Friend BD; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. bdfriend@texaschildrens.org., Muhsen IN; Department of Medicine, Houston Methodist Hospital, Houston, TX, USA., Patel S; Department of Pediatrics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA., Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Pingali SR; Houston Methodist Cancer Center, Houston, TX, USA., Kamble RT; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., John TD; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Salem B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Bhar S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Doherty EE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Craddock J; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Sasa G; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Wu M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Wang T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Krance RA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Carrum G; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2022 Apr; Vol. 57 (4), pp. 579-585. Date of Electronic Publication: 2022 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Hodgkin Disease*/drug therapy , Hodgkin Disease*/pathology, Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Carmustine/therapeutic use ; Child ; Cytarabine ; Humans ; Melphalan ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Retrospective Studies ; Rituximab/therapeutic use ; Transplantation Conditioning ; Transplantation, Autologous ; Young Adult

المؤلفون: Ononamadu CJ; Nigeria Police Academy, Department of Biochemistry and Forensic Science, Kano, Nigeria., Abdalla M; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Shandong Province, 250012, PR China., Ihegboro GO; Nigeria Police Academy, Department of Biochemistry and Forensic Science, Kano, Nigeria., Li J; Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Shandong Province, 250012, PR China., Owolarafe TA; Nigeria Police Academy, Department of Biochemistry and Forensic Science, Kano, Nigeria., John TD; Federal University Dutse, Department of Microbiology and Biotechnology, Kano, Nigeria., Tian Q; Department of Senile Neurology, The Central Hospital of Taian, Taian, Shandong, 271000, PR China.

المصدر: Biochemistry and biophysics reports [Biochem Biophys Rep] 2021 Nov 30; Vol. 28, pp. 101178. Date of Electronic Publication: 2021 Nov 30 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101660999 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5808 (Electronic) Linking ISSN: 24055808 NLM ISO Abbreviation: Biochem Biophys Rep Subsets: PubMed not MEDLINE

المؤلفون: John TD; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA. tami.john@bcm.edu., Friend B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Yassine K; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Sasa G; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Bhar S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Salem B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Omer B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Craddock J; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Doherty E; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Houston, TX, USA., Krance RA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Leung K; Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2021 Nov; Vol. 56 (11), pp. 2797-2803. Date of Electronic Publication: 2021 Jul 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/therapy , Graft vs Host Disease*/drug therapy , Hematopoietic Stem Cell Transplantation*, Aged ; Alemtuzumab/therapeutic use ; Hospitals ; Humans ; Retrospective Studies ; Texas ; Transplantation Conditioning ; Unrelated Donors